Related Experiment Video
Updated: Jul 5, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Application value of miRNA-182 as a biomarker for cancer diagnosis: a systematic review with meta-analysis
Mengyu Shang1, Mengdan Ma2, Ganglin Su2
1School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen, 518060, China.
Abstract:
Aim: This study aims to establish the potential reliability and validity of miRNA-182 as a diagnostic tool in oncology, and hence to contribute to the decision-making process in clinical settings. Materials & methods: To further evaluate the role of miRNA-182 as a cancer biomarker, we conducted a search of the PubMed, Cochrane Library, Wanfang and China National Knowledge Infrastructure databases of existing literature. Conclusion: These results suggest that miRNA-182 could function as a potential molecular marker for cancer detection and diagnosis. The effect of miRNA-182 on tumor development should be further studied to confirm these results and add to the current understanding of its role in cancer.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs

